Monthly Stock Pick

free monthly stock pick emailed to you for a year

Thank you for subscribing to the Free Monthly Stock Pick.
This month's pick is posted below and future Picks will be sent to you by email.
The Pick is Not a recommendation and we only recommend a portfolio approach for investing.
The pick is either part of our model portfolio or a high-rated pick if the Portfolio is in Cash.
Opening price of 1st trading day after publication is used to calculate performance.

Complete access to the Model Portfolio is available with a paid subscription.
With a 60-day money back guarantee, you can always try out.
Samples available in the Small Cap section above.

Stock Pick for Jan 2023: INMD

Stock Pick for Dec 2022: EXTR -4%

Stock Pick for Nov 2022: HLIT -2%

Stock Pick for Oct 2022: CALX +17%

Stock Pick for Sep 2022: No Pick (market conditions)

Stock Pick for Aug 2022: TMDX +27%

Stock Pick for May, Jun, Jul, 2022: No Picks (market conditions)

Stock Pick for Apr 2022: LXU -6%

Stock Pick for Mar 2022: VET +13%

Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‘Graycell’ and/or ‘we,’ is a publisher of financial information, such as the Prudent Small Cap, Prudent Biotech, and Prudent Healthcare newsletters. We are not a Registered Investment Advisor (RIA). Historical performance figures provided are hypothetical, unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period. Hypothetical or simulated performance results have limitations, and unlike an actual performance record, simulated results do not represent actual trading and consequently do not involve the financial risk of actual trading. The performance results obtained are intended for illustrative purposes only. No representation is being made that any account will or is likely to achieve profit or losses similar to those shown. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, the biotech industry and small caps are characterized by much higher risk and volatility than the general stock market. Information contained herein is general and does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your investment decisions. Use of the information herein is at one's own risk. We are simply sharing the results of our model. Nothing should be construed as a recommendation or an offer to buy or sell any securities, and we are not liable nor do we assume any liability or responsibility for losses incurred as a result of any information provided or not provided or not made available on time, herein or on our website or using any other medium. We cannot guarantee the accuracy and completeness of any information furnished by us. We may or may not have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or can be licensed and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their due diligence with any potential investment and consider obtaining professional advice before making an investment decision.


Enter your details below to get instant access to [enter lead magnet name here]

We process your personal data as stated in our Privacy Policy. You may withdraw your consent at any time by clicking the unsubscribe link at the bottom of any of our emails.